等待开盘 03-25 09:30:00 美东时间
-0.150
-0.06%
Nanobiotix (NBTX) shares rose ~7% in Paris on Wednesday after the French publication La Lettre reported that U.S. pharma giant Johnson & Johnson (JNJ) is eyeing a buyout deal to acquire the cancer dru...
今天 19:03
ARM Holdings PLC Sponsored ADR涨10.23%;赫克拉矿业涨6.80%;科尔黛伦矿业涨6.44%
今天 16:22
Mike Johnson says US can lead the AI race if government limits control and industry acts as a patriotic partner for global AI dominance.
今天 15:45
EXCLUSIVE-FBI investigation into Kash Patel was more extensive than previously reported Two grand jury subpoenas issued by Special Counsel Jack Smith to Verizon requested extensive records The probe sought phone, email, and text records as well as usernames and IP addresses The subpoenas came during
03-24 18:00
(来源:抗体圈) 公开资料显示,特立妥单抗是一款双特异性T细胞衔接器,通过同时结合表达于T细胞表面的CD3受体,以及表达于多发性骨髓瘤细胞和部分健康B系细...
03-24 15:34
BUZZ-UK betting stocks rise on report of possible U.S. ban on sports bets on prediction markets ** Shares in UK betting companies Flutter Entertainment and Entain spike higher; up 9% and 4.1% respectively; topping FTSE 350 ** Traders point to WSJ report that U.S. lawmakers are to introduce bipartisa
03-23 18:40
Daré Bioscience introduces DARE to PLAY™ Sildenafil Cream, the first topical arousal cream specifically developed for women, addressing the gap in evidence-based solutions for female sexual health. Unlike Viagra, which was designed for men, DARE to PLAY™ delivers sildenafil directly to enhance genital blood flow and arousal in women.clinically studied and formulated for female physiology, it is now available as a Section 503B compounded product, ...
03-23 12:00
Royalty Pharma appoints Lucas Glass as Head of Artificial Intelligence, effective April 2026. With over a decade of experience in AI and data solutions, Glass will lead the implementation of cutting-edge AI capabilities, enhancing the company's decision-making and operational efficiency. His appointment underscores Royalty Pharma's commitment to leveraging advanced technologies to strengthen its competitive edge in the biopharmaceutical sector.
03-23 11:15
Analysts at financial-services firm UBS identified a group of high-conviction U.S. industrial stocks, pointing to double-digit upside across sectors as earnings growth and valuation re-rating drive re...
03-22 23:16
公司名称
|
强生
|
行业分类
|
制药
|
业务描述
|
强生是全球具综合性、业务分布范围广的医疗保健企业,业务涉及消费品、制药、医疗器材三大领域,1985年在华创立了第一家合资企业。强生遵循企业信条的价值观,致力于践行“关爱全世界,关注每个人”的健康愿景,以领先的科技研发创造创新的理念、产品和服务,为改善人类健康和福祉而不懈努力。每天,强生遍布世界各地的员工,与他们的合作方一起,为全球消费者和病患带来更健康、更快乐、更长寿的生活。
|
Nanobiotix (NBTX) shares rose ~7% in Paris on Wednesday after the French publication La Lettre reported that U.S. pharma giant Johnson & Johnson (JNJ) is eyeing a buyout deal to acquire the cancer dru...
今天 19:03
ARM Holdings PLC Sponsored ADR涨10.23%;赫克拉矿业涨6.80%;科尔黛伦矿业涨6.44%
今天 16:22
Mike Johnson says US can lead the AI race if government limits control and industry acts as a patriotic partner for global AI dominance.
今天 15:45
EXCLUSIVE-FBI investigation into Kash Patel was more extensive than previously reported Two grand jury subpoenas issued by Special Counsel Jack Smith to Verizon requested extensive records The probe sought phone, email, and text records as well as usernames and IP addresses The subpoenas came during
03-24 18:00
(来源:抗体圈) 公开资料显示,特立妥单抗是一款双特异性T细胞衔接器,通过同时结合表达于T细胞表面的CD3受体,以及表达于多发性骨髓瘤细胞和部分健康B系细...
03-24 15:34
BUZZ-UK betting stocks rise on report of possible U.S. ban on sports bets on prediction markets ** Shares in UK betting companies Flutter Entertainment and Entain spike higher; up 9% and 4.1% respectively; topping FTSE 350 ** Traders point to WSJ report that U.S. lawmakers are to introduce bipartisa
03-23 18:40
Daré Bioscience introduces DARE to PLAY™ Sildenafil Cream, the first topical arousal cream specifically developed for women, addressing the gap in evidence-based solutions for female sexual health. Unlike Viagra, which was designed for men, DARE to PLAY™ delivers sildenafil directly to enhance genital blood flow and arousal in women.clinically studied and formulated for female physiology, it is now available as a Section 503B compounded product, ...
03-23 12:00
Royalty Pharma appoints Lucas Glass as Head of Artificial Intelligence, effective April 2026. With over a decade of experience in AI and data solutions, Glass will lead the implementation of cutting-edge AI capabilities, enhancing the company's decision-making and operational efficiency. His appointment underscores Royalty Pharma's commitment to leveraging advanced technologies to strengthen its competitive edge in the biopharmaceutical sector.
03-23 11:15
Analysts at financial-services firm UBS identified a group of high-conviction U.S. industrial stocks, pointing to double-digit upside across sectors as earnings growth and valuation re-rating drive re...
03-22 23:16
派息除权日
|
每股总股息
| 派息日期 |
2026-02-24
|
1.30
|
2026-03-10
|
2025-11-25
|
1.30
|
2025-12-09
|
2025-08-26
|
1.30
|
2025-09-09
|
2025-05-27
|
1.30
|
2025-06-10
|
2025-02-18
|
1.24
|
2025-03-04
|
2024-11-26
|
1.24
|
2024-12-10
|
2024-08-27
|
1.24
|
2024-09-10
|
2024-05-20
|
1.24
|
2024-06-04
|
2024-02-16
|
1.19
|
2024-03-05
|
2023-11-20
|
1.19
|
2023-12-05
|
2023-08-25
|
1.19
|
2023-09-07
|
2023-05-22
|
1.19
|
2023-06-06
|
2023-02-17
|
1.13
|
2023-03-07
|
2022-11-21
|
1.13
|
2022-12-06
|
2022-08-22
|
1.13
|
2022-09-06
|
2022-05-23
|
1.13
|
2022-06-07
|
2022-02-18
|
1.06
|
2022-03-08
|
2021-11-22
|
1.06
|
2021-12-07
|
2021-08-23
|
1.06
|
2021-09-07
|
2021-05-24
|
1.06
|
2021-06-08
|
2021-02-22
|
1.01
|
2021-03-09
|
2020-11-23
|
1.01
|
2020-12-08
|
2020-08-24
|
1.01
|
2020-09-08
|
2020-05-22
|
1.01
|
2020-06-09
|
2020-02-24
|
0.95
|
2020-03-10
|
2019-11-25
|
0.95
|
2019-12-10
|
2019-08-26
|
0.95
|
2019-09-10
|
2019-05-24
|
0.95
|
2019-06-11
|
2019-02-25
|
0.90
|
2019-03-12
|
2018-11-26
|
0.90
|
2018-12-11
|
2018-08-27
|
0.90
|
2018-09-11
|
2018-05-25
|
0.90
|
2018-06-12
|
2018-02-26
|
0.84
|
2018-03-13
|
2017-11-27
|
0.84
|
2017-12-12
|
2017-08-25
|
0.84
|
2017-09-12
|
2017-05-25
|
0.84
|
2017-06-13
|
2017-02-24
|
0.80
|
2017-03-14
|
2016-11-18
|
0.80
|
2016-12-06
|
2016-08-19
|
0.80
|
2016-09-06
|
2016-05-20
|
0.80
|
2016-06-07
|
2016-02-19
|
0.75
|
2016-03-08
|
2015-11-20
|
0.75
|
2015-12-08
|
2015-08-21
|
0.75
|
2015-09-08
|
2015-05-21
|
0.75
|
2015-06-09
|
2015-02-20
|
0.70
|
2015-03-10
|
2014-11-21
|
0.70
|
2014-12-09
|
2014-08-22
|
0.70
|
2014-09-09
|
2014-05-22
|
0.70
|
2014-06-10
|
2014-02-21
|
0.66
|
2014-03-11
|
2013-11-22
|
0.66
|
2013-12-10
|
2013-08-23
|
0.66
|
2013-09-10
|
2013-05-23
|
0.66
|
2013-06-11
|
2013-02-22
|
0.61
|
2013-03-12
|
2012-11-23
|
0.61
|
2012-12-11
|
2012-08-24
|
0.61
|
2012-09-11
|
2012-05-24
|
0.61
|
2012-06-12
|
2012-02-24
|
0.57
|
2012-03-13
|
2011-11-25
|
0.57
|
2011-12-13
|
2011-08-26
|
0.57
|
2011-09-13
|
2011-05-26
|
0.57
|
2011-06-14
|
2011-02-25
|
0.54
|
2011-03-15
|
2010-11-26
|
0.54
|
2010-12-14
|
2010-08-27
|
0.54
|
2010-09-14
|
2010-05-27
|
0.54
|
2010-06-15
|
2010-02-19
|
0.49
|
2010-03-09
|
2009-11-20
|
0.49
|
2009-12-08
|
2009-08-21
|
0.49
|
2009-09-08
|
2009-05-21
|
0.49
|
2009-06-09
|
2009-02-20
|
0.46
|
2009-03-10
|
2008-11-21
|
0.46
|
2008-12-09
|
2008-08-22
|
0.46
|
2008-09-09
|
2008-05-22
|
0.46
|
2008-06-10
|
2008-02-22
|
0.41
|
2008-03-11
|
2007-11-23
|
0.41
|
2007-12-11
|
2007-08-24
|
0.41
|
2007-09-11
|
2007-05-24
|
0.41
|
2007-06-12
|
2007-02-23
|
0.38
|
2007-03-13
|
2006-11-24
|
0.38
|
2006-12-12
|
2006-08-25
|
0.38
|
2006-09-12
|
2006-05-25
|
0.38
|
2006-06-13
|
2006-02-24
|
0.33
|
2006-03-14
|
2005-11-18
|
0.33
|
2005-12-13
|
2005-08-19
|
0.33
|
2005-09-13
|
2005-05-13
|
0.33
|
2005-06-07
|
2005-02-11
|
0.28
|
2005-03-08
|
2004-11-12
|
0.28
|
2004-12-07
|
2004-08-13
|
0.28
|
2004-09-07
|
2004-05-14
|
0.28
|
2004-06-08
|
2004-02-12
|
0.24
|
2004-03-09
|
2003-11-14
|
0.24
|
2003-12-09
|
2003-08-15
|
0.24
|
2003-09-09
|
2003-05-16
|
0.24
|
2003-06-10
|
2003-02-13
|
0.20
|
2003-03-11
|
2002-11-15
|
0.20
|
2002-12-10
|
2002-08-16
|
0.20
|
2002-09-10
|
2002-05-17
|
0.20
|
2002-06-11
|
2002-02-14
|
0.18
|
2002-03-12
|
2001-11-16
|
0.18
|
2001-12-11
|
2001-08-17
|
0.18
|
2001-09-11
|
2001-05-18
|
0.36
|
2001-06-12
|
2001-02-15
|
0.32
|
2001-03-13
|
2000-11-17
|
0.32
|
2000-12-12
|
2000-08-18
|
0.32
|
2000-09-12
|
2000-05-19
|
0.32
|
2000-06-13
|
2000-02-11
|
0.28
|
2000-03-07
|
1999-11-12
|
0.28
|
1999-12-07
|
1999-08-13
|
0.28
|
1999-09-07
|
1999-05-14
|
0.28
|
1999-06-08
|
1999-02-11
|
0.25
|
1999-03-09
|
1998-11-13
|
0.25
|
1998-12-08
|
1998-08-14
|
0.25
|
1998-09-08
|
1998-05-15
|
0.25
|
1998-06-09
|
1998-02-12
|
0.22
|
1998-03-10
|
1997-11-14
|
0.22
|
1997-12-09
|
1997-08-15
|
0.22
|
1997-09-09
|
1997-05-16
|
0.22
|
1997-06-10
|
1997-02-13
|
0.19
|
1997-03-11
|
1996-11-15
|
0.19
|
1996-12-10
|
1996-08-16
|
0.19
|
1996-09-10
|
1996-05-17
|
0.38
|
1996-06-11
|
1996-02-15
|
0.33
|
1996-03-12
|
1995-11-10
|
0.33
|
1995-12-05
|
1995-08-11
|
0.33
|
1995-09-05
|
1995-05-10
|
0.33
|
1995-06-06
|
1995-02-08
|
0.29
|
1995-03-07
|
1994-11-08
|
0.29
|
1994-12-06
|
1994-08-10
|
0.29
|
1994-09-06
|
1994-05-11
|
0.29
|
1994-06-07
|
1994-02-09
|
0.26
|
1994-03-08
|
1993-11-09
|
0.26
|
1993-12-07
|
1993-08-11
|
0.26
|
1993-09-07
|
1993-05-12
|
0.26
|
1993-06-08
|
1993-02-09
|
0.23
|
1993-03-09
|
1992-11-10
|
0.23
|
1992-12-08
|
1992-08-12
|
0.23
|
1992-09-08
|
1992-05-13
|
0.46
|
1992-06-09
|
1992-02-11
|
0.40
|
1992-03-10
|
1991-11-13
|
0.40
|
1991-12-10
|
1991-08-14
|
0.40
|
1991-09-10
|
1991-05-15
|
0.40
|
1991-06-11
|
1991-02-12
|
0.34
|
1991-03-12
|
1990-11-14
|
0.34
|
1990-12-04
|
1990-08-15
|
0.34
|
1990-09-04
|
1990-05-16
|
0.34
|
1990-06-05
|
1990-02-13
|
0.29
|
1990-03-06
|
1989-11-15
|
0.29
|
1989-12-05
|
1989-08-16
|
0.29
|
1989-09-05
|
1989-05-22
|
0.29
|
1989-06-06
|
1989-02-14
|
0.50
|
1989-03-07
|
1988-11-16
|
0.50
|
1988-12-06
|
1988-08-17
|
0.50
|
1988-09-06
|
1988-05-18
|
0.50
|
1988-06-07
|
1988-02-17
|
0.42
|
1988-03-08
|
1987-11-16
|
0.42
|
1987-12-10
|
1987-08-17
|
0.42
|
1987-09-10
|
1987-05-22
|
0.42
|
1987-06-11
|
1987-02-23
|
0.35
|
1987-03-12
|
1986-11-17
|
0.35
|
1986-12-11
|
1986-08-18
|
0.35
|
1986-09-11
|
1986-05-23
|
0.35
|
1986-06-12
|
1986-02-04
|
0.32
|
1986-03-13
|
1985-11-18
|
0.32
|
1985-12-12
|
1985-08-19
|
0.32
|
1985-09-12
|
1985-05-24
|
0.32
|
1985-06-13
|
1985-02-15
|
0.30
|
1985-03-14
|
1984-11-16
|
0.30
|
1984-12-13
|
1984-08-20
|
0.30
|
1984-09-13
|
1984-05-21
|
0.30
|
1984-06-14
|
1984-02-17
|
0.28
|
1984-03-08
|
1983-11-14
|
0.28
|
1983-12-08
|
1983-08-15
|
0.28
|
1983-09-08
|
1983-05-16
|
0.28
|
1983-06-09
|
1983-02-18
|
0.25
|
1983-03-10
|
1982-11-15
|
0.25
|
1982-12-09
|
1982-08-16
|
0.25
|
1982-09-09
|
1982-05-17
|
0.25
|
1982-06-10
|
1982-02-22
|
0.22
|
1982-03-11
|
1981-11-16
|
0.22
|
1981-12-10
|
1981-08-17
|
0.22
|
1981-09-10
|
1981-05-22
|
0.22
|
1981-06-11
|
1981-02-13
|
0.57
|
1981-03-11
|
1980-11-17
|
0.57
|
1980-12-11
|
1980-08-18
|
0.57
|
1980-09-11
|
1980-05-19
|
0.57
|
1980-06-11
|
1980-02-14
|
0.50
|
1980-03-10
|
1979-11-15
|
0.50
|
1979-12-11
|
1979-08-19
|
0.50
|
1979-09-11
|
1979-05-20
|
0.50
|
1979-06-11
|
1979-02-19
|
0.50
|
1979-03-11
|
1978-11-12
|
0.43
|
1978-12-07
|
1978-08-13
|
0.43
|
1978-09-07
|
1978-05-14
|
0.43
|
1978-06-07
|
1978-02-09
|
0.43
|
1978-03-07
|
1977-11-13
|
0.35
|
1977-12-08
|
1977-08-14
|
0.35
|
1977-09-08
|
1977-05-15
|
0.35
|
1977-06-08
|
1977-02-17
|
0.25
|
1977-03-08
|
